Literature DB >> 23606722

Integrin Regulation during Leukocyte Recruitment.

Jan Herter1, Alexander Zarbock.   

Abstract

Integrins are recognized as vital players in leukocyte recruitment. Integrin malfunction causes severe disease patterns characterized by the inability to fight pathogens. Although inflammatory reactions are beneficial and necessary for host defense, these reactions have to be controlled to prevent tissue destruction and harmful sequelae. In this review, we discuss the different signaling pathways leading to the change of integrin adhesiveness in neutrophils, monocytes, and lymphocytes. We thereby focus on the importance of integrin activation for the different steps of the leukocyte recruitment cascade, including rolling, adhesion, postadhesion strengthening, intravascular crawling, and transmigration, as each step necessitates the proper functioning of a distinct set of integrin molecules that has to be activated specifically. Additionally, we discuss endogenous mechanisms that balance and counteract integrin activation and limit leukocyte recruitment at the site of inflammation. Further insight into these complex mechanisms may provide new approaches for developing new anti-inflammatory therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23606722     DOI: 10.4049/jimmunol.1203179

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).

Authors:  Aftab A Ansari; Siddappa N Byrareddy
Journal:  Int Trends Immun       Date:  2016-01

Review 2.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

3.  The role of nitric oxide in regulation of leukocyte migration into the heart tissue in vitro.

Authors:  A A Petenkova; R I Kovalenko; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2016-01-05

4.  Midkine, a middle manager of β2 integrins.

Authors:  Jan M Herter; Tanya N Mayadas
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 5.  From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins.

Authors:  Ioannis Kourtzelis; Ioannis Mitroulis; Janusz von Renesse; George Hajishengallis; Triantafyllos Chavakis
Journal:  J Leukoc Biol       Date:  2017-03-14       Impact factor: 4.962

Review 6.  The role of neutrophils and NETosis in autoimmune and renal diseases.

Authors:  Sarthak Gupta; Mariana J Kaplan
Journal:  Nat Rev Nephrol       Date:  2016-05-31       Impact factor: 28.314

Review 7.  Functional significance of mononuclear phagocyte populations generated through adult hematopoiesis.

Authors:  Michael F Gutknecht; Amy H Bouton
Journal:  J Leukoc Biol       Date:  2014-09-15       Impact factor: 4.962

Review 8.  Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.

Authors:  Edward Allan Racela Sison; Peter Kurre; Yong-Mi Kim
Journal:  Pediatr Hematol Oncol       Date:  2017-12-06       Impact factor: 1.969

9.  Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.

Authors:  Almudena Ortega-Gomez; Melanie Salvermoser; Jan Rossaint; Robert Pick; Janine Brauner; Patricia Lemnitzer; Jessica Tilgner; Renske J de Jong; Remco T A Megens; Janina Jamasbi; Yvonne Döring; Christine T Pham; Christoph Scheiermann; Wolfgang Siess; Maik Drechsler; Christian Weber; Jochen Grommes; Alexander Zarbock; Barbara Walzog; Oliver Soehnlein
Journal:  Circulation       Date:  2016-09-22       Impact factor: 29.690

10.  Integrin α4β1 controls G9a activity that regulates epigenetic changes and nuclear properties required for lymphocyte migration.

Authors:  Xiaohong Zhang; Peter C Cook; Egor Zindy; Craig J Williams; Thomas A Jowitt; Charles H Streuli; Andrew S MacDonald; Javier Redondo-Muñoz
Journal:  Nucleic Acids Res       Date:  2015-12-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.